Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KDM1 is a novel therapeutic target for the treatment of gliomas

17 Nov 2012

Abstract excerpt

// Gangadhara R. Sareddy 1 , Binoj C. Nair 1 , Samaya K. Krishnan 1 , Vijay K. Gonugunta 1 , Quan-guang Zhang 2 , Takayoshi Suzuki 3,4 , Naoki Miyata 5 , Andrew J. Brenner 6 , 7 , Darrell W. Brann 2 and Ratna K. Vadlamudi 1,7 1 The Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio TX 2 Institute of Molecular Medicine and Genetics, Georgia Health...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Genomics and Chromatin Dynamics
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23248157
DOI: 10.18632/oncotarget.725

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KDM1 is a novel therapeutic target for the treatment of gliomasPMID 23248157Read ↗

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growthSemantic proximity Read ↗

Potential Epigenetic-Based Therapeutic Targets for GliomaSemantic proximity Read ↗

The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cellsSemantic proximity Read ↗

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastomaSemantic proximity Read ↗

Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathwaySemantic proximity Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

The Chromatin-Oxygen Sensor Gene KDM5C Associates with Novel Hypoxia-Related Signatures in Glioblastoma MultiformeSemantic proximity Read ↗

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM 2BSemantic proximity Read ↗

Advances in epigenetic glioblastoma therapySemantic proximity Read ↗

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-MycSemantic proximity Read ↗

m1A RNA Methylation Regulators Contribute To Malignant Progression And Have Clinical Prognostic Impact In GliomasSemantic proximity Read ↗

Histone Lysine-to-Methionine Mutation as Anticancer Drug Target.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.